Valuation Update With 7 Day Price Move • 4h
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹13.71, the stock trades at a trailing P/E ratio of 15.3x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 133% over the past three years. Valuation Update With 7 Day Price Move • Apr 06
Investor sentiment improves as stock rises 31% After last week's 31% share price gain to ₹12.63, the stock trades at a trailing P/E ratio of 14.1x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 166% over the past three years. New Risk • Apr 01
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.6% average weekly change). Market cap is less than US$100m (₹1.46b market cap, or US$15.7m). Reported Earnings • Feb 23
Third quarter 2026 earnings released: EPS: ₹0.17 (vs ₹0.40 in 3Q 2025) Third quarter 2026 results: EPS: ₹0.17 (down from ₹0.40 in 3Q 2025). Revenue: ₹659.4m (up 9.2% from 3Q 2025). Net income: ₹23.3m (down 57% from 3Q 2025). Profit margin: 3.5% (down from 9.0% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 109% per year but the company’s share price has only increased by 35% per year, which means it is significantly lagging earnings growth. Reported Earnings • Nov 13
Second quarter 2026 earnings released: EPS: ₹0.37 (vs ₹0.31 in 2Q 2025) Second quarter 2026 results: EPS: ₹0.37 (up from ₹0.31 in 2Q 2025). Revenue: ₹673.8m (up 17% from 2Q 2025). Net income: ₹49.5m (up 17% from 2Q 2025). Profit margin: 7.3% (down from 7.4% in 2Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 117% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Sep 08
Upcoming dividend of ₹0.05 per share Eligible shareholders must have bought the stock before 12 September 2025. Payment date: 18 October 2025. Payout ratio is a comfortable 4.3% and this is well supported by cash flows. Trailing yield: 0.3%. Lower than top quartile of Indian dividend payers (1.3%). Lower than average of industry peers (0.7%). Declared Dividend • Aug 25
Dividend of ₹0.05 announced Dividend of ₹0.05 is the same as last year. Ex-date: 12th September 2025 Payment date: 19th October 2025 Dividend yield will be 0.3%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is well covered by both earnings (4% earnings payout ratio) and cash flows (19% cash payout ratio). The company is yet to establish a track record of dividend growth or stability as it hasn't paid a regular dividend for at least 2 years. Earnings per share has grown by 32% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Reported Earnings • Aug 12
First quarter 2026 earnings released: EPS: ₹0.13 (vs ₹0.21 in 1Q 2025) First quarter 2026 results: EPS: ₹0.13 (down from ₹0.21 in 1Q 2025). Revenue: ₹590.1m (up 17% from 1Q 2025). Net income: ₹17.2m (down 40% from 1Q 2025). Profit margin: 2.9% (down from 5.7% in 1Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 104% per year but the company’s share price has only increased by 46% per year, which means it is significantly lagging earnings growth. Tillkännagivande • Aug 11
Jaysynth Orgochem Limited, Annual General Meeting, Sep 19, 2025 Jaysynth Orgochem Limited, Annual General Meeting, Sep 19, 2025. Tillkännagivande • Aug 02
Jaysynth Orgochem Limited to Report Q1, 2026 Results on Aug 11, 2025 Jaysynth Orgochem Limited announced that they will report Q1, 2026 results on Aug 11, 2025 Reported Earnings • May 29
Full year 2025 earnings released: EPS: ₹1.16 (vs ₹0.91 in FY 2024) Full year 2025 results: EPS: ₹1.16 (up from ₹0.91 in FY 2024). Revenue: ₹2.31b (up 9.3% from FY 2024). Net income: ₹156.2m (up 27% from FY 2024). Profit margin: 6.7% (up from 5.8% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 89% per year but the company’s share price has only increased by 46% per year, which means it is significantly lagging earnings growth. Tillkännagivande • May 28
Jaysynth Orgochem Limited Recommends Dividend for the Financial Year Ended 31 March 2025 Jaysynth Orgochem Limited announced that at its board meeting held on 28 May 2025, recommended the payment of dividend for the financial year ended 31 March 2025 at 5% that is INR 0.05 per equity shares having face value of INR 1 each, subject To Approve the Members at the upcoming Annual General Meeting of the Company. Tillkännagivande • May 19
Jaysynth Orgochem Limited to Report Q4, 2025 Results on May 28, 2025 Jaysynth Orgochem Limited announced that they will report Q4, 2025 results on May 28, 2025 New Risk • May 19
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Market cap is less than US$100m (₹3.24b market cap, or US$37.9m). Valuation Update With 7 Day Price Move • May 16
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹22.24, the stock trades at a trailing P/E ratio of 20x. Average trailing P/E is 26x in the Chemicals industry in India. Total returns to shareholders of 201% over the past three years. Reported Earnings • Feb 13
Third quarter 2025 earnings released: EPS: ₹0.40 (vs ₹0.32 in 3Q 2024) Third quarter 2025 results: EPS: ₹0.40 (up from ₹0.32 in 3Q 2024). Revenue: ₹618.7m (up ₹616.4m from 3Q 2024). Net income: ₹54.6m (up ₹50.3m from 3Q 2024). Profit margin: 8.8% (down from 182% in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 69% per year whereas the company’s share price has increased by 65% per year. Tillkännagivande • Feb 04
Jaysynth Orgochem Limited to Report Q3, 2025 Results on Feb 12, 2025 Jaysynth Orgochem Limited announced that they will report Q3, 2025 results on Feb 12, 2025 Valuation Update With 7 Day Price Move • Jan 20
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹27.82, the stock trades at a trailing P/E ratio of 28.6x. Average trailing P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 447% over the past three years. Tillkännagivande • Nov 04
Jaysynth Orgochem Limited to Report Q2, 2025 Results on Nov 12, 2024 Jaysynth Orgochem Limited announced that they will report Q2, 2025 results on Nov 12, 2024 Valuation Update With 7 Day Price Move • Oct 14
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹20.35, the stock trades at a trailing P/E ratio of 20x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 240% over the past three years. Tillkännagivande • Sep 24
Jaysynth Orgochem Limited Announces Cessation of Trikamdas Chandan as Independent Director Jaysynth Orgochem Limited informed that Umesh Trikamdas Chandan (DIN: 00184677) ceased to be an Independent Director of the Company upon completion of his second term of 5 (Five) consecutive years w.e.f. closure of business hours on 23rd September, 2024. Upcoming Dividend • Sep 11
Upcoming dividend of ₹0.05 per share Eligible shareholders must have bought the stock before 18 September 2024. Payment date: 26 October 2024. Payout ratio is a comfortable 5.5% and this is well supported by cash flows. Trailing yield: 0.3%. Lower than top quartile of Indian dividend payers (1.0%). Lower than average of industry peers (0.6%). Valuation Update With 7 Day Price Move • Aug 21
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹19.35, the stock trades at a trailing P/E ratio of 19x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 198% over the past three years. Buy Or Sell Opportunity • Aug 06
Now 21% undervalued Over the last 90 days, the stock has risen 25% to ₹15.66. The fair value is estimated to be ₹19.93, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 158% over the last 3 years. Meanwhile, the company has become profitable. Tillkännagivande • Aug 03
Jaysynth Orgochem Limited to Report Q1, 2025 Results on Aug 13, 2024 Jaysynth Orgochem Limited announced that they will report Q1, 2025 results on Aug 13, 2024 Buy Or Sell Opportunity • Jul 08
Now 22% overvalued after recent price rise Over the last 90 days, the stock has risen 172% to ₹21.22. The fair value is estimated to be ₹17.45, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 158% over the last 3 years. Meanwhile, the company has become profitable. Valuation Update With 7 Day Price Move • Jun 29
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₹16.80, the stock trades at a trailing P/E ratio of 18.4x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 433% over the past three years. Valuation Update With 7 Day Price Move • Jun 12
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹13.83, the stock trades at a trailing P/E ratio of 15.2x. Average trailing P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 355% over the past three years. Tillkännagivande • May 31
JD Orgochem Limited Proposes Dividend for the Financial Year Ended 31 March, 2024 JD Orgochem Limited announced that Board of Directors of the Company at its Meeting held on 29th May, 2024, recommended payment of Dividend for the financial year ended 31st March, 2024 @ 5% i.e. 0.05 per equity shares having face value of 1/- each, subject To Approve the Members at the Annual General Meeting of the Company. Tillkännagivande • May 30
Jd Orgochem Limited Announces Resignation of Bharati Ravindra Chandan and Mitesh Dilip Sejpal from the Position of Non-Executive Independent Director JD Orgochem Limited at its Board Meeting held on 29th May, 2024, resignation of Bharati Ravindra Chandan and Mitesh Dilip Sejpal from the position of Non-Executive Independent Director of the Company effective 29th May, 2024. Tillkännagivande • May 23
JD Orgochem Limited to Report Q4, 2024 Results on May 29, 2024 JD Orgochem Limited announced that they will report Q4, 2024 results on May 29, 2024 New Risk • May 10
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Over 9x increase in shares outstanding. This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₹38m free cash flow). Negative equity (-₹266m). Earnings have declined by 54% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 9x increase in shares outstanding). Revenue is less than US$1m (₹7.5m revenue, or US$89k). Minor Risks Share price has been volatile over the past 3 months (9.1% average weekly change). Market cap is less than US$100m (₹1.69b market cap, or US$20.3m). Tillkännagivande • Feb 05
JD Orgochem Limited to Report Q3, 2024 Results on Feb 13, 2024 JD Orgochem Limited announced that they will report Q3, 2024 results at 3:30 PM, Indian Standard Time on Feb 13, 2024 New Risk • Nov 15
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₹38m free cash flow). Share price has been highly volatile over the past 3 months (9.0% average weekly change). Negative equity (-₹266m). Earnings have declined by 61% per year over the past 5 years. Revenue is less than US$1m (₹1.0m revenue, or US$12k). Market cap is less than US$10m (₹99.8m market cap, or US$1.20m). Reported Earnings • Nov 12
Second quarter 2024 earnings released: ₹0.07 loss per share (vs ₹5.15 loss in 2Q 2023) Second quarter 2024 results: ₹0.07 loss per share (improved from ₹5.15 loss in 2Q 2023). Revenue: ₹3.70m (down 7.0% from 2Q 2023). Net loss: ₹1.03m (loss narrowed 99% from 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has increased by 34% per year, which means it is well ahead of earnings. Tillkännagivande • Nov 01
JD Orgochem Limited to Report Q2, 2024 Results on Nov 09, 2023 JD Orgochem Limited announced that they will report Q2, 2024 results on Nov 09, 2023 Tillkännagivande • Sep 28
JD Orgochem Limited Appoints Maitri Bhayani as Company Secretary and Compliance Officer JD Orgochem Limited has appointed Ms. Maitri Bhayani (Membership No. A68431) Member of Institute of Company Secretaries of India as Company Secretary and Compliance Officer of the Company with effect from 27th September, 2023. Ms. Maitri Bhayani (Membership No. A68431) is an associate member of the Institute of Company Secretaries of India and is also Commerce Graduate. She possesses over 2 years of post qualification experience. She has vast exposure in dealing with compliances of Public and Private Companies. Tillkännagivande • Aug 09
JD Orgochem Limited, Annual General Meeting, Sep 25, 2023 JD Orgochem Limited, Annual General Meeting, Sep 25, 2023. Reported Earnings • Aug 09
First quarter 2024 earnings released: ₹0.25 loss per share (vs ₹0.06 profit in 1Q 2023) First quarter 2024 results: ₹0.25 loss per share (down from ₹0.06 profit in 1Q 2023). Revenue: ₹421.0k (down 90% from 1Q 2023). Net loss: ₹3.25m (down 491% from profit in 1Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 99 percentage points per year, which is a significant difference in performance. Tillkännagivande • Aug 01
JD Orgochem Limited to Report Q1, 2024 Results on Aug 08, 2023 JD Orgochem Limited announced that they will report Q1, 2024 results on Aug 08, 2023 Tillkännagivande • May 06
JD Orgochem Limited to Report Q4, 2023 Results on May 12, 2023 JD Orgochem Limited announced that they will report Q4, 2023 results on May 12, 2023 Tillkännagivande • Feb 11
JD Orgochem Limited Announces Resignation of Shivani S. Kawle as Company Secretary and Compliance Officer, Effective March 31, 2023 JD Orgochem Limited announced that Ms. Shivani S. Kawle has tendered her resignation from the post of Company Secretary and Compliance Officer (Key Managerial Personnel) of the Company. The Company has accepted her resignation and relieved her from duties with effect from close of business hours of 31st March, 2023. She tendered her resignation to pursue opportunities outside the Company. Tillkännagivande • Feb 03
JD Orgochem Limited to Report Q3, 2023 Results on Feb 10, 2023 JD Orgochem Limited announced that they will report Q3, 2023 results on Feb 10, 2023 Tillkännagivande • Jan 26
JD Orgochem Limited (BSE:524592) entered into a scheme of implementation to acquire Jaysynth Dyestuff (India) Limited and Jaysynth Impex Private Limited. JD Orgochem Limited (BSE:524592) entered into a scheme of implementation to acquire Jaysynth Dyestuff (India) Limited and Jaysynth Impex Private Limited on January 24, 2023. As per the terms, JD Orgochem will issue 14 fully paid up equity shares JD Orgochem allotted for every 1 share held by the Equity Shareholders of Jaysynth Dyestuff (India) Limited, and 252 fully paid up 2% Redeemable Non-convertible Non-Cumulative
Non-Participating Preference Shares of JD Orgochem to be issued and allotted for every 1 each held by the Equity Shareholders of Jaysynth Impex Private. Board Change • Nov 17
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Whole Time Director Suhas Jande was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Tillkännagivande • Nov 03
JD Orgochem Limited to Report Q2, 2023 Results on Nov 10, 2022 JD Orgochem Limited announced that they will report Q2, 2023 results on Nov 10, 2022 Tillkännagivande • Jul 30
JD Orgochem Limited to Report Q1, 2023 Results on Aug 08, 2022 JD Orgochem Limited announced that they will report Q1, 2023 results at 12:00 PM, Indian Standard Time on Aug 08, 2022 Tillkännagivande • Jul 13
JD Orgochem Limited, Annual General Meeting, Aug 08, 2022 JD Orgochem Limited, Annual General Meeting, Aug 08, 2022, at 15:00 Indian Standard Time. Tillkännagivande • May 21
JD Orgochem Limited to Report Q4, 2022 Results on May 30, 2022 JD Orgochem Limited announced that they will report Q4, 2022 results on May 30, 2022 Board Change • Apr 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. Whole Time Director Suhas Jande was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Apr 02
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. Whole Time Director Suhas Jande was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Feb 13
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: ₹0.13 loss per share (up from ₹0.24 loss in 3Q 2021). Revenue: ₹9.46m (up 224% from 3Q 2021). Net loss: ₹1.81m (loss narrowed 42% from 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 94 percentage points per year, which is a significant difference in performance. Tillkännagivande • Feb 11
JD Orgochem Limited Announces Appointment of Shivani Shailesh Kawle as Company Secretary and Compliance Officer JD Orgochem Limited announced at the board meeting held on February 10, 2022 that the company approved appointment Ms. Shivani Shailesh Kawle Member of Institute of Company Secretaries of India as Company Secretary and Compliance Officer of the Company with effect from 10 February, 2022. Tillkännagivande • Feb 03
JD Orgochem Limited to Report Q3, 2022 Results on Feb 10, 2022 JD Orgochem Limited announced that they will report Q3, 2022 results on Feb 10, 2022 Reported Earnings • Jul 04
Full year 2021 earnings released: ₹0.67 loss per share (vs ₹0.86 loss in FY 2020) The company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2021 results: Revenue: ₹19.8m (up 32% from FY 2020). Net loss: ₹8.52m (loss narrowed 25% from FY 2020). Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings. Is New 90 Day High Low • Feb 18
New 90-day low: ₹2.81 The company is down 6.0% from its price of ₹2.99 on 19 November 2020. The Indian market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period. Tillkännagivande • Feb 13
JD Orgochem Limited Announces Appointment of Kantibhai Maganbhai Darji as Chief Financial Officer and Key Managerial Personnel JD Orgochem Limited announced that at its Board meeting held on 11th February, 2021, approved the appointment of Kantibhai Maganbhai Darji as Chief Financial Officer and Key Managerial Personnel of the Company. Mr. Kantibhai Maganbhai Darji has been appointed as Chief Financial Officer (CFO)and Key Managerial Personnel (KMP) of the Company with effect from 11th February, 2021. Mr. Kantibhai Maganbhai Darji is a commerce graduate & possesses over 30 years of experience across various fields such as banking, finance, fund management, budgeting etc. He is well conversant with the industry, commerce and trade. Tillkännagivande • Feb 02
JD Orgochem Limited to Report Q3, 2021 Results on Feb 11, 2021 JD Orgochem Limited announced that they will report Q3, 2021 results on Feb 11, 2021 Is New 90 Day High Low • Dec 23
New 90-day high: ₹3.13 The company is up 4.0% from its price of ₹3.02 on 18 September 2020. The Indian market is up 19% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 18% over the same period. Tillkännagivande • Dec 18
JD Orgochem Limited Announces the Resignation of Narendra Ramanlal Shah from Key Managerial Personnel JD Orgochem Limited announced that Narendra Ramanlal Shah, Chief Financial Officer and Key Managerial Personnel of the Company, has tendered his resignation dated 15th December, 2020 and he will be relieved from the duties with effect from closing hours of 31st December, 2020. The company is in the process of appointing a new Chief Financial Officer and same will be communicated to the Stock Exchange in due course. Tillkännagivande • Dec 17
JD Orgochem Limited Announces the Resignation of Narendra Ramanlal Shah as Chief Financial Officer JD Orgochem Limited announced that Narendra Ramanlal Shah, Chief Financial Officer and Key Managerial Personnel of the Company, has tendered his resignation dated 15th December, 2020 and he will be relieved from the duties with effect from closing hours of 31st December, 2020. The company is in the process of appointing a new Chief Financial Officer and same will be communicated to the Stock Exchange in due course. Tillkännagivande • Nov 11
JD Orgochem Limited to Report Q2, 2021 Results on Nov 10, 2020 JD Orgochem Limited announced that they will report Q2, 2021 results on Nov 10, 2020 Tillkännagivande • Sep 04
JD Orgochem Limited to Report Q1, 2021 Results on Sep 11, 2020 JD Orgochem Limited announced that they will report Q1, 2021 results on Sep 11, 2020 Tillkännagivande • Jul 17
JD Orgochem Limited to Report Q4, 2020 Results on Jul 14, 2020 JD Orgochem Limited announced that they will report Q4, 2020 results on Jul 14, 2020